Erratum: Cell cycle-dependent expression of DuB3, Nanog and the p160 family of Nuclear Receptor Coactivators (NCoAs) in mouse embryonic stem cells PLoS ONE (2014) 9, 4 (e93663) DOI: 10.1371/journal.pone.0093663;Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Van Der Laan, Siem ^a   Golfetto, Eleonora ^a   Vanacker, Jean Marc ^b   Maiorano, Domenico ^a  

^a INSTITUTE OF HUMAN GENETICS   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; CYCLINE E1; DEUBIQUITINASE; DEUBIQUITINASE 3; ESTROGEN RELATED RECEPTOR BETA; NUCLEAR RECEPTOR COACTIVATOR; NUCLEAR RECEPTOR COACTIVATOR 2; PROTEIN P160; STEROID RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; DUB3 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; NANOG PROTEIN, MOUSE; PROTEINASE; RHO KINASE; ROCK1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FATE; CONTROLLED STUDY; DNA DAMAGE; EMBRYONIC STEM CELL; G1 PHASE CELL CYCLE CHECKPOINT; NONHUMAN; PHASE TRANSITION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; CELL CYCLE; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HAPLORHINI; METABOLISM; MOUSE; PHYSIOLOGY; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CELL CYCLE; CELL LINE; DNA DAMAGE; EMBRYONIC STEM CELLS; ENDOPEPTIDASES; GENE EXPRESSION REGULATION; HAPLORHINI; HOMEODOMAIN PROTEINS; MICE; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RHO-ASSOCIATED KINASES; TRANSCRIPTION, GENETIC;

EID: 84898870604     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105649     Document Type: Erratum

References (41)

1. Newport J, Kirschner M (1982) A major developmental transition in early Xenopus embryos: II. Control of the onset of transcription. Cell 30: 687-696. (Pubitemid 13204658)
2. Edgar BA, O'Farrel PH (1989) Genetic control of cell division patterns in the Drosphila embryo. Cell 57: 177-187. (Pubitemid 19098879)
3. Norbury C, Nurse P (1992) Animal cell cycles and their control. Annual review of biochemistry 61: 441-470.
4. Smith AG (2001) Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 17: 435-462.
5. Pauklin S, Vallier L (2013) The cell-cycle state of stem cells determines cell fate propensity. Cell 155: 135-147.
6. van der Laan S, Tsanov N, Crozet C, Maiorano D (2013) High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. Molecular cell 52: 366-379.
7. Pereg Y, Liu BY, O'Rourke KM, Sagolla M, Dey A, et al. (2010) Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. Nat Cell Biol 12: 400-406.
8. Busino L, Chiesa M, Draetta GF, Donzelli M (2004) Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis. Oncogene 23: 2050-2056. (Pubitemid 38496734)
9. Horard B, Vanacker JM (2003) Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand. Journal of molecular endocrinology 31: 349-357. (Pubitemid 38054510)
10. Tremblay AM, Giguere V (2007) The NR3B subgroup: an ovERRview. Nuclear receptor signaling 5: e009.
11. Vanacker JM, Bonnelye E, Chopin-Delannoy S, Delmarre C, Cavailles V, et al. (1999) Transcriptional activities of the orphan nuclear receptor ERR alpha (estrogen receptor-related receptor-alpha). Molecular endocrinology 13: 764-773. (Pubitemid 30645329)
12. Deblois G, Hall JA, Perry MC, Laganiere J, Ghahremani M, et al. (2009) Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity. Cancer research 69: 6149-6157.
13. Papp B, Plath K (2012) Pluripotency re-centered around Esrrb. The EMBO journal 31: 4255-4257.
14. Deblois G, St-Pierre J, Giguere V (2013) The PGC-1/ERR signaling axis in cancer. Oncogene 32: 3483-3490.
15. Xie W, Hong H, Yang NN, Lin RJ, Simon CM, et al. (1999) Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2. Molecular endocrinology 13: 2151-2162. (Pubitemid 30637273)
16. Lu D, Kiriyama Y, Lee KY, Giguere V (2001) Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors. Cancer research 61: 6755-6761. (Pubitemid 32898670)
17. Schreiber SN, Knutti D, Brogli K, Uhlmann T, Kralli A (2003) The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha). The Journal of biological chemistry 278: 9013-9018. (Pubitemid 36800379)
18. Giguere V (2008) Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocrine reviews 29: 677-696.
19. Villena JA, Kralli A (2008) ERRalpha: a metabolic function for the oldest orphan. Trends in endocrinology and metabolism: TEM 19: 269-276.
20. van der Laan S, Meijer OC (2008) Pharmacology of glucocorticoids: beyond receptors. European journal of pharmacology 585: 483-491.
21. Xu J, Li Q (2003) Review of the in vivo functions of the p160 steroid receptor coactivator family. Molecular endocrinology 17: 1681-1692. (Pubitemid 37072287)
22. Meijer OC, Kalkhoven E, van der Laan S, Steenbergen PJ, Houtman SH, et al. (2005) Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling. Endocrinology 146: 1438-1448. (Pubitemid 40289333)
23. Kalkhoven E, Valentine JE, Heery DM, Parker MG (1998) Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. The EMBO journal 17: 232-243. (Pubitemid 28041064)
24. Percharde M, Lavial F, Ng JH, Kumar V, Tomaz RA, et al. (2012) Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming. Genes & development 26: 2286-2298.
25. Shibue T, Takeda K, Oda E, Tanaka H, Murasawa H, et al. (2003) Integral role of Noxa in p53-mediated apoptotic response. Genes & development 17: 2233-2238. (Pubitemid 37128638)
26. Murray AW (2004) Recycling the cell cycle: cyclins revisited. Cell 116: 221-234.
27. Buschhorn BA, Peters JM (2006) How APC/C orders destruction. Nature cell biology 8: 209-211.
28. Uranishi K, Akagi T, Sun C, Koide H, Yokota T (2013) Dax1 associates with esrrb and regulates its function in embryonic stem cells. Mol Cell Biol 33: 2056-2066.
29. Deblois G, Hall JA, Perry MC, Laganiere J, Ghahremani M, et al. (2009) Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity. Cancer Res 69: 6149-6157.
30. Bianco S, Lanvin O, Tribollet V, Macari C, North S, et al. (2009) Modulating estrogen receptor-related receptor-alpha activity inhibits cell proliferation. The Journal of biological chemistry 284: 23286-23292.
31. Yu S, Wong YC, Wang XH, Ling MT, Ng CF, et al. (2008) Orphan nuclear receptor estrogen-related receptor-beta suppresses in vitro and in vivo growth of prostate cancer cells via p21(WAF1/CIP1) induction and as a potential therapeutic target in prostate cancer. Oncogene 27: 3313-3328. (Pubitemid 351733386)
32. Yu S, Wang X, Ng CF, Chen S, Chan FL (2007) ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer. Cancer research 67: 4904-4914. (Pubitemid 46915313)
33. Chambers I, Colby D, Robertson M, Nichols J, Lee S, et al. (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655. (Pubitemid 36694189)
34. Singh AM, Chappell J, Trost R, Lin L, Wang T, et al. (2013) Cell-cycle control of developmentally regulated transcription factors accounts for heterogeneity in human pluripotent cells. Stem cell reports 1: 532-544.
35. Zhang X, Neganova I, Przyborski S, Yang C, Cooke M, et al. (2009) A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A. J Cell Biol 184: 67-82.
36. Kuijk EW, van Tol LT, Van de Velde H, Wubbolts R, Welling M, et al. (2012) The roles of FGF and MAP kinase signaling in the segregation of the epiblast and hypoblast cell lineages in bovine and human embryos. Development 139: 871-882.
37. Roode M, Blair K, Snell P, Elder K, Marchant S, et al. (2012) Human hypoblast formation is not dependent on FGF signalling. Developmental Biology 361: 358-363.
38. McFarlane C, Kelvin AA, de la Vega M, Govender U, Scott CJ, et al. (2010) The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression. Cancer research 70: 3329-3339.
39. Frietze S, Lupien M, Silver PA, Brown M (2008) CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. Cancer research 68: 301-306. (Pubitemid 351380132)
40. Feng Q, Yi P, Wong J, O'Malley BW (2006) Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly. Molecular and cellular biology 26: 7846-7857. (Pubitemid 44630986)
41. Naeem H, Cheng D, Zhao Q, Underhill C, Tini M, et al. (2007) The activity and stability of the transcriptional coactivator p/CIP/SRC-3 are regulated by CARM1-dependent methylation. Molecular and cellular biology 27: 120-134. (Pubitemid 46013238)